329 related articles for article (PubMed ID: 21859738)
1. Cytotoxic molecule-positive classical Hodgkin's lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type.
Asano N; Kinoshita T; Tamaru J; Ohshima K; Yoshino T; Niitsu N; Tsukamoto N; Hirabayashi K; Izutsu K; Taniwaki M; Morishima Y; Nakamura S
Haematologica; 2011 Nov; 96(11):1636-43. PubMed ID: 21859738
[TBL] [Abstract][Full Text] [Related]
2. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S
Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519
[TBL] [Abstract][Full Text] [Related]
3. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
4. [Classical Hodgkin's lymphoma: biology and grey zones].
Gaulard P; Brousse N
Ann Pathol; 2004 Sep; 24(4):330-48. PubMed ID: 15567950
[TBL] [Abstract][Full Text] [Related]
5. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
6. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
Cool CD; Bitter MA
Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
[TBL] [Abstract][Full Text] [Related]
7. Rare expression of T-cell markers in classical Hodgkin's lymphoma.
Tzankov A; Bourgau C; Kaiser A; Zimpfer A; Maurer R; Pileri SA; Went P; Dirnhofer S
Mod Pathol; 2005 Dec; 18(12):1542-9. PubMed ID: 16056244
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM
Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472
[TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
Kamper P; Bendix K; Hamilton-Dutoit S; Honoré B; Nyengaard JR; d'Amore F
Haematologica; 2011 Feb; 96(2):269-76. PubMed ID: 21071500
[TBL] [Abstract][Full Text] [Related]
10. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
11. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
12. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma.
Tzankov A; Zimpfer A; Went P; Maurer R; Pileri SA; Geley S; Dirnhofer S
Mod Pathol; 2005 Jan; 18(1):90-6. PubMed ID: 15389259
[TBL] [Abstract][Full Text] [Related]
14. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
Hansmann ML; Fellbaum C; Hui PK; Lennert K
Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
[TBL] [Abstract][Full Text] [Related]
15. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
16. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's disease of Waldeyer's ring. Clinical and histoimmunophenotypic findings and association with Epstein-Barr virus in 16 cases.
Kapadia SB; Roman LN; Kingma DW; Jaffe ES; Frizzera G
Am J Surg Pathol; 1995 Dec; 19(12):1431-9. PubMed ID: 7503365
[TBL] [Abstract][Full Text] [Related]
18. LGALS3 as a prognostic factor for classical Hodgkin's lymphoma.
Koh YW; Jung SJ; Park CS; Yoon DH; Suh C; Huh J
Mod Pathol; 2014 Oct; 27(10):1338-44. PubMed ID: 24603587
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma.
Asano N; Suzuki R; Matsuo K; Kagami Y; Ishida F; Tamaru JI; Jin GS; Sato Y; Shimoyama Y; Yoshino T; Morishima Y; Nakamura S
Histopathology; 2007 May; 50(6):705-15. PubMed ID: 17493234
[TBL] [Abstract][Full Text] [Related]
20. CD15, CD30, and PAX5 evaluation in Hodgkin's lymphoma on fine-needle aspiration cytology samples.
Cozzolino I; Vitagliano G; Caputo A; Montella M; Franco R; Ciancia G; Selleri C; Zeppa P
Diagn Cytopathol; 2020 Mar; 48(3):211-216. PubMed ID: 31825183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]